The cluster of director purchases, while small in absolute terms, is a rare bullish insider signal for MDWD. Monitor for upcoming catalysts (earnings, NexoBrid milestones) that may have prompted the buying. The 92% analyst bullish consensus suggests the market is already optimistic, so the signal is confirmatory rather than transformative.
MDWD drugs
MDWD drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 2 $13.76entry
- T+1 · 6mo ago −0.22%α +0.48% · $13.73
- T+5 · 5mo ago +3.92%α +6.89% · $14.30
- T+20 · 5mo ago +7.70%α +9.27% · $14.82
- T+60 · 3mo ago −7.70%α −8.82% · $12.70
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two MediWound directors made open-market purchases totaling $27K over a 4-day window. While the dollar amount is small relative to the $178M market cap (0.015%), cluster buys by directors are a modestly positive signal, especially given the company's 92% analyst bullish consensus.
Key Financial Metrics
Key Facts
- Director David Morton Fox purchased 1,730 shares at $14.225 on June 1, 2026, for ~$24.6K.
- Director Samuel Rubinstein purchased 150 shares at $14.33 on May 29, 2026, for ~$2.1K.
- Total insider buying: $26.8K, representing ~0.015% of market cap.
- Both transactions were open-market purchases (code P), not grants or exercises.
- No insider sales were reported in the same window.
Financial Impact
Total insider purchases of $26.8K, negligible relative to $178M market cap.
Risk Factors
- Purchase amounts are very small relative to market cap, limiting signal strength.
- Directors may be buying for diversification or personal reasons, not informational edge.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MDWD-1780399845353 |
Track record
13 reports on MDWD
5 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +20.80% at T+60 after the Mar 5, 2026 report. 6 of 7 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $12.90 Now $13.55 +5.04% settles Nov 20
- Nov 12, 20264d ago 6-K Bearish 6/10 No price data
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $12.97 Now $13.55 −4.47% settles Nov 19
- Nov 5, 202611d ago 6-K Bearish 6/10 Entry $13.33 to $12.97 Now $13.55 −1.65% ▲ +2.70% +5.99% vs SPY
- Nov 5, 202611d ago 424B5 Bearish 5/10 Entry $13.33 to $12.97 Now $13.55 −1.65% ▲ +2.70% +5.99% vs SPY
- Nov 3, 202613d ago 424B5 Bearish 5/10 Entry $14.20 to $13.82 Now $13.55 +4.58% ▲ +2.68% +1.76% vs SPY
- Sep 22, 20267w ago Press Release Bullish 4/10 Entry $13.95 to $13.80 Now $13.55 −2.87% ▼ −1.08% +0.11% vs SPY
- Jun 2, 202623w ago Insider Cluster Bullish 4/10 Viewing Entry $13.76 to $14.30 Now $13.55 −1.53% ▲ +3.92% +6.89% vs SPY
- May 27, 202624w ago Press Release Bearish 5/10 Entry $14.33 to $13.73 Now $13.55 +5.44% ▲ +4.19% +4.66% vs SPY
- May 7, 202627w ago Press Release Neutral 1/10 Entry $17.27 to $16.25 Now $13.55 −21.54% ▼ −5.91% −7.41% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers